Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells
Dysregulated RNA modifications contribute to cancer progression and therapy resistance, yet the underlying mechanism often remains unknown. Here, we perform CRISPR-based synthetic lethality screens to systematically explore the role of RNA modifications in mediating resistance to antileukemic drugs....
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 13 2025
|
| In: |
Blood
Year: 2025, Jahrgang: 146, Heft: 20, Pages: 2443-2456 |
| ISSN: | 1528-0020 |
| DOI: | 10.1182/blood.2024027822 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood.2024027822
|
| Verfasserangaben: | Cornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank, Oguzhan Begik, Christian Rohde, Sarah Miriam Naomi Zimmermann, Laura Werner, Daniel Heid, Fu Xu, Katharina Weidenauer, Sylvain Delaunay, Nadja Krall, Katrin Trunk, Duoduo Zhao, Fengbiao Zhou, Laia Llovera, Alexane Ollivier, Anke Heit-Mondrzyk, Uwe Platzbecker, Claudia Baldus, Hubert Serve, Martin Bornhäuser, Cathrine Broberg Vågbø, Salvador Aznar Benitah, Jeroen Krijgsveld, Eva Maria Novoa, Carsten Müller-Tidow, and Michaela Frye |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1950594742 | ||
| 003 | DE-627 | ||
| 005 | 20260202091930.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 260129s2025 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1182/blood.2024027822 |2 doi | |
| 035 | |a (DE-627)1950594742 | ||
| 035 | |a (DE-599)KXP1950594742 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pauli, Cornelius |d 1993- |e VerfasserIn |0 (DE-588)121916402X |0 (DE-627)1734922249 |4 aut | |
| 245 | 1 | 0 | |a Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells |c Cornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank, Oguzhan Begik, Christian Rohde, Sarah Miriam Naomi Zimmermann, Laura Werner, Daniel Heid, Fu Xu, Katharina Weidenauer, Sylvain Delaunay, Nadja Krall, Katrin Trunk, Duoduo Zhao, Fengbiao Zhou, Laia Llovera, Alexane Ollivier, Anke Heit-Mondrzyk, Uwe Platzbecker, Claudia Baldus, Hubert Serve, Martin Bornhäuser, Cathrine Broberg Vågbø, Salvador Aznar Benitah, Jeroen Krijgsveld, Eva Maria Novoa, Carsten Müller-Tidow, and Michaela Frye |
| 264 | 1 | |c November 13 2025 | |
| 300 | |b Illustrationen | ||
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 29.01.2026 | ||
| 520 | |a Dysregulated RNA modifications contribute to cancer progression and therapy resistance, yet the underlying mechanism often remains unknown. Here, we perform CRISPR-based synthetic lethality screens to systematically explore the role of RNA modifications in mediating resistance to antileukemic drugs. We identify the tRNA methyltransferase 5 (TRMT5)-mediated formation of N1-methylguanosine (m1G) in the transfer RNA (tRNA) anticodon loop as essential for mediating drug tolerance to cytarabine and venetoclax (Ven) in acute myeloid leukemia (AML). TRMT5 methylates nearly all mitochondrial and nuclear tRNAs with a guanosine at position 37, but its role in promoting drug tolerance specifically depends on its mitochondrial function. TRMT5 is essential for the dynamic upregulation of mitochondrial messenger RNA translation and oxidative phosphorylation, which are critical for sustaining drug tolerance in leukemia cells. This mitochondrial dependency correlates with therapy outcomes in patients with leukemia: lower expression of electron transport chain genes is linked to poorer outcomes in a cohort of nearly 100 patients with AML undergoing first induction therapy. Finally, we demonstrate that targeted depletion of the TRMT5 protein using a conditional degron, in conjunction with cytarabine and Ven treatment, synergistically induces cell death in drug-tolerant AML cells. Thus, our study reveals TRMT5 as a promising drug target for therapy-resistant leukemia. | ||
| 700 | 1 | |a Kienhöfer, Michael |e VerfasserIn |0 (DE-588)138832167X |0 (DE-627)1950595153 |4 aut | |
| 700 | 1 | |a Blank, Maximilian Felix |d 1990- |e VerfasserIn |0 (DE-588)1148021574 |0 (DE-627)1007497351 |0 (DE-576)496147528 |4 aut | |
| 700 | 1 | |a Begik, Oguzhan |e VerfasserIn |4 aut | |
| 700 | 1 | |a Rohde, Christian |e VerfasserIn |0 (DE-588)1164191675 |0 (DE-627)1028653816 |0 (DE-576)508428939 |4 aut | |
| 700 | 1 | |a Zimmermann, Sarah |e VerfasserIn |0 (DE-588)1388322226 |0 (DE-627)1950595854 |4 aut | |
| 700 | 1 | |a Werner, Laura |e VerfasserIn |0 (DE-588)1388322722 |0 (DE-627)1950596435 |4 aut | |
| 700 | 1 | |a Heid, Daniel |d 1994- |e VerfasserIn |0 (DE-588)120879146X |0 (DE-627)1695629256 |4 aut | |
| 700 | 1 | |a Xu, Fu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Weidenauer, Katharina |d 1997- |e VerfasserIn |0 (DE-588)1302314165 |0 (DE-627)1859328474 |4 aut | |
| 700 | 1 | |a Delaunay, Sylvain |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krall, Nadja |e VerfasserIn |0 (DE-588)138832329X |0 (DE-627)1950597083 |4 aut | |
| 700 | 1 | |a Trunk, Katrin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zhao, Duoduo |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zhou, Fengbiao |d 1983- |e VerfasserIn |0 (DE-588)1060649128 |0 (DE-627)800416376 |0 (DE-576)416777082 |4 aut | |
| 700 | 1 | |a Llovera, Laia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ollivier, Alexane |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heit-Mondrzyk, Anke |e VerfasserIn |4 aut | |
| 700 | 1 | |a Platzbecker, Uwe |e VerfasserIn |4 aut | |
| 700 | 1 | |a Baldus, Claudia |d 1972- |e VerfasserIn |0 (DE-588)122672631 |0 (DE-627)705995054 |0 (DE-576)293374945 |4 aut | |
| 700 | 1 | |a Serve, Hubert |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bornhäuser, Martin |d 1966- |e VerfasserIn |0 (DE-588)1167559118 |0 (DE-627)1031176071 |0 (DE-576)511198817 |4 aut | |
| 700 | 1 | |a Vågbø, Cathrine Broberg |e VerfasserIn |4 aut | |
| 700 | 1 | |a Benitah, Salvador Aznar |e VerfasserIn |4 aut | |
| 700 | 1 | |a Krijgsveld, Jeroen |e VerfasserIn |0 (DE-588)1163292125 |0 (DE-627)1027502032 |0 (DE-576)507882474 |4 aut | |
| 700 | 1 | |a Novoa, Eva Maria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Müller-Tidow, Carsten |d 1968- |e VerfasserIn |0 (DE-588)1015101798 |0 (DE-627)705330230 |0 (DE-576)351197893 |4 aut | |
| 700 | 1 | |a Frye, Michaela |e VerfasserIn |0 (DE-588)1251446477 |0 (DE-627)1789106443 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 146(2025), 20 vom: Nov., Seite 2443-2456 |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnas |a Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells |
| 773 | 1 | 8 | |g volume:146 |g year:2025 |g number:20 |g month:11 |g pages:2443-2456 |g extent:14 |a Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells |
| 856 | 4 | 0 | |u https://doi.org/10.1182/blood.2024027822 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |7 1 |
| 951 | |a AR | ||
| 992 | |a 20260129 | ||
| 993 | |a Article | ||
| 994 | |a 2025 | ||
| 998 | |g 1251446477 |a Frye, Michaela |m 1251446477:Frye, Michaela |d 50000 |e 50000PF1251446477 |k 0/50000/ |p 28 |y j | ||
| 998 | |g 1015101798 |a Müller-Tidow, Carsten |m 1015101798:Müller-Tidow, Carsten |d 910000 |d 910100 |e 910000PM1015101798 |e 910100PM1015101798 |k 0/910000/ |k 1/910000/910100/ |p 27 | ||
| 998 | |g 1163292125 |a Krijgsveld, Jeroen |m 1163292125:Krijgsveld, Jeroen |d 50000 |e 50000PK1163292125 |k 0/50000/ |p 25 | ||
| 998 | |g 1060649128 |a Zhou, Fengbiao |m 1060649128:Zhou, Fengbiao |d 910000 |d 910100 |e 910000PZ1060649128 |e 910100PZ1060649128 |k 0/910000/ |k 1/910000/910100/ |p 15 | ||
| 998 | |g 138832329X |a Krall, Nadja |m 138832329X:Krall, Nadja |d 50000 |e 50000PK138832329X |k 0/50000/ |p 12 | ||
| 998 | |g 1302314165 |a Weidenauer, Katharina |m 1302314165:Weidenauer, Katharina |p 10 | ||
| 998 | |g 120879146X |a Heid, Daniel |m 120879146X:Heid, Daniel |p 8 | ||
| 998 | |g 1388322722 |a Werner, Laura |m 1388322722:Werner, Laura |d 50000 |e 50000PW1388322722 |k 0/50000/ |p 7 | ||
| 998 | |g 1388322226 |a Zimmermann, Sarah |m 1388322226:Zimmermann, Sarah |d 50000 |e 50000PZ1388322226 |k 0/50000/ |p 6 | ||
| 998 | |g 1164191675 |a Rohde, Christian |m 1164191675:Rohde, Christian |d 910000 |d 910100 |e 910000PR1164191675 |e 910100PR1164191675 |k 0/910000/ |k 1/910000/910100/ |p 5 | ||
| 998 | |g 1148021574 |a Blank, Maximilian Felix |m 1148021574:Blank, Maximilian Felix |d 910000 |d 910100 |e 910000PB1148021574 |e 910100PB1148021574 |k 0/910000/ |k 1/910000/910100/ |p 3 | ||
| 998 | |g 138832167X |a Kienhöfer, Michael |m 138832167X:Kienhöfer, Michael |d 910000 |d 910100 |d 50000 |e 910000PK138832167X |e 910100PK138832167X |e 50000PK138832167X |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 2 | ||
| 998 | |g 121916402X |a Pauli, Cornelius |m 121916402X:Pauli, Cornelius |d 50000 |e 50000PP121916402X |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1950594742 |e 486437483X | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"doi":["10.1182/blood.2024027822"],"eki":["1950594742"]},"name":{"displayForm":["Cornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank, Oguzhan Begik, Christian Rohde, Sarah Miriam Naomi Zimmermann, Laura Werner, Daniel Heid, Fu Xu, Katharina Weidenauer, Sylvain Delaunay, Nadja Krall, Katrin Trunk, Duoduo Zhao, Fengbiao Zhou, Laia Llovera, Alexane Ollivier, Anke Heit-Mondrzyk, Uwe Platzbecker, Claudia Baldus, Hubert Serve, Martin Bornhäuser, Cathrine Broberg Vågbø, Salvador Aznar Benitah, Jeroen Krijgsveld, Eva Maria Novoa, Carsten Müller-Tidow, and Michaela Frye"]},"physDesc":[{"extent":"14 S.","noteIll":"Illustrationen"}],"recId":"1950594742","note":["Gesehen am 29.01.2026"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title_sort":"Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells","title":"Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells"}],"person":[{"display":"Pauli, Cornelius","family":"Pauli","role":"aut","given":"Cornelius"},{"display":"Kienhöfer, Michael","family":"Kienhöfer","given":"Michael","role":"aut"},{"role":"aut","given":"Maximilian Felix","family":"Blank","display":"Blank, Maximilian Felix"},{"family":"Begik","given":"Oguzhan","role":"aut","display":"Begik, Oguzhan"},{"given":"Christian","role":"aut","family":"Rohde","display":"Rohde, Christian"},{"display":"Zimmermann, Sarah","family":"Zimmermann","given":"Sarah","role":"aut"},{"display":"Werner, Laura","family":"Werner","role":"aut","given":"Laura"},{"display":"Heid, Daniel","family":"Heid","role":"aut","given":"Daniel"},{"display":"Xu, Fu","family":"Xu","given":"Fu","role":"aut"},{"display":"Weidenauer, Katharina","given":"Katharina","role":"aut","family":"Weidenauer"},{"display":"Delaunay, Sylvain","family":"Delaunay","given":"Sylvain","role":"aut"},{"role":"aut","given":"Nadja","family":"Krall","display":"Krall, Nadja"},{"given":"Katrin","role":"aut","family":"Trunk","display":"Trunk, Katrin"},{"given":"Duoduo","role":"aut","family":"Zhao","display":"Zhao, Duoduo"},{"display":"Zhou, Fengbiao","role":"aut","given":"Fengbiao","family":"Zhou"},{"given":"Laia","role":"aut","family":"Llovera","display":"Llovera, Laia"},{"role":"aut","given":"Alexane","family":"Ollivier","display":"Ollivier, Alexane"},{"given":"Anke","role":"aut","family":"Heit-Mondrzyk","display":"Heit-Mondrzyk, Anke"},{"role":"aut","given":"Uwe","family":"Platzbecker","display":"Platzbecker, Uwe"},{"role":"aut","given":"Claudia","family":"Baldus","display":"Baldus, Claudia"},{"display":"Serve, Hubert","role":"aut","given":"Hubert","family":"Serve"},{"display":"Bornhäuser, Martin","role":"aut","given":"Martin","family":"Bornhäuser"},{"display":"Vågbø, Cathrine Broberg","given":"Cathrine Broberg","role":"aut","family":"Vågbø"},{"display":"Benitah, Salvador Aznar","family":"Benitah","role":"aut","given":"Salvador Aznar"},{"display":"Krijgsveld, Jeroen","given":"Jeroen","role":"aut","family":"Krijgsveld"},{"display":"Novoa, Eva Maria","family":"Novoa","given":"Eva Maria","role":"aut"},{"display":"Müller-Tidow, Carsten","role":"aut","given":"Carsten","family":"Müller-Tidow"},{"given":"Michaela","role":"aut","family":"Frye","display":"Frye, Michaela"}],"relHost":[{"origin":[{"dateIssuedDisp":"1946-","dateIssuedKey":"1946","publisherPlace":"Washington, DC ; Philadelphia, Pa. ; Stanford, Calif.","publisher":"American Society of Hematology ; Saunders ; HighWire Press"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 21.04.2023"],"title":[{"subtitle":"journal of the American Society of Hematology","title":"Blood","title_sort":"Blood"}],"physDesc":[{"extent":"Online-Ressource"}],"recId":"266886647","disp":"Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cellsBlood","corporate":[{"role":"isb","display":"American Society of Hematology"}],"titleAlt":[{"title":"Blood online"}],"pubHistory":["1.1946 -"],"id":{"issn":["1528-0020"],"eki":["266886647"],"zdb":["1468538-3"]},"part":{"issue":"20","text":"146(2025), 20 vom: Nov., Seite 2443-2456","extent":"14","pages":"2443-2456","volume":"146","year":"2025"}}],"origin":[{"dateIssuedKey":"2025","dateIssuedDisp":"November 13 2025"}]} | ||
| SRT | |a PAULICORNEDISRUPTING1320 | ||